Your browser doesn't support javascript.
loading
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis.
Koh, Eun Hee; Yoon, Ji Eun; Ko, Myoung Seok; Leem, Jaechan; Yun, Ji-Young; Hong, Chung Hwan; Cho, Yun Kyung; Lee, Seung Eun; Jang, Jung Eun; Baek, Ji Yeon; Yoo, Hyun Ju; Kim, Su Jung; Sung, Chang Ohk; Lim, Joon Seo; Jeong, Won-Il; Back, Sung Hoon; Baek, In-Jeoung; Torres, Sandra; Solsona-Vilarrasa, Estel; Conde de la Rosa, Laura; Garcia-Ruiz, Carmen; Feldstein, Ariel E; Fernandez-Checa, Jose C; Lee, Ki-Up.
Affiliation
  • Koh EH; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Yoon JE; Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Ko MS; Biomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Leem J; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Yun JY; Biomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Hong CH; Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Cho YK; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee SE; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Jang JE; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Baek JY; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Yoo HJ; The Convergence Medicine Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim SJ; The Convergence Medicine Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Sung CO; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lim JS; Clinical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Jeong WI; Laboratory of Liver Research, Graduate School of Medical Science and Engineering, KAIST, Daejeon, South Korea.
  • Back SH; School of Biological Sciences, University of Ulsan, Ulsan, South Korea.
  • Baek IJ; The Convergence Medicine Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Torres S; Department of Cell Death and Proliferation, Instituto Investigaciones Biomédicas de Barcelona (IIBB), CSIC, Barcelona, Spain and Liver Unit-IDIBAPS and Centro de Investigación Biomédica en Red (CIBERehd), Barcelona, Spain.
  • Solsona-Vilarrasa E; Department of Cell Death and Proliferation, Instituto Investigaciones Biomédicas de Barcelona (IIBB), CSIC, Barcelona, Spain and Liver Unit-IDIBAPS and Centro de Investigación Biomédica en Red (CIBERehd), Barcelona, Spain.
  • Conde de la Rosa L; Department of Cell Death and Proliferation, Instituto Investigaciones Biomédicas de Barcelona (IIBB), CSIC, Barcelona, Spain and Liver Unit-IDIBAPS and Centro de Investigación Biomédica en Red (CIBERehd), Barcelona, Spain.
  • Garcia-Ruiz C; Department of Cell Death and Proliferation, Instituto Investigaciones Biomédicas de Barcelona (IIBB), CSIC, Barcelona, Spain and Liver Unit-IDIBAPS and Centro de Investigación Biomédica en Red (CIBERehd), Barcelona, Spain.
  • Feldstein AE; University of Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Fernandez-Checa JC; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
  • Lee KU; Department of Cell Death and Proliferation, Instituto Investigaciones Biomédicas de Barcelona (IIBB), CSIC, Barcelona, Spain and Liver Unit-IDIBAPS and Centro de Investigación Biomédica en Red (CIBERehd), Barcelona, Spain kulee@amc.seoul.kr checa229@yahoo.com.
Gut ; 70(10): 1954-1964, 2021 10.
Article in En | MEDLINE | ID: mdl-33208407
ABSTRACT

OBJECTIVE:

Lipotoxic hepatocyte injury is a primary event in non-alcoholic steatohepatitis (NASH), but the mechanisms of lipotoxicity are not fully defined. Sphingolipids and free cholesterol (FC) mediate hepatocyte injury, but their link in NASH has not been explored. We examined the role of free cholesterol and sphingomyelin synthases (SMSs) that generate sphingomyelin (SM) and diacylglycerol (DAG) in hepatocyte pyroptosis, a specific form of programmed cell death associated with inflammasome activation, and NASH.

DESIGN:

Wild-type C57BL/6J mice were fed a high fat and high cholesterol diet (HFHCD) to induce NASH. Hepatic SMS1 and SMS2 expressions were examined in various mouse models including HFHCD-fed mice and patients with NASH. Pyroptosis was estimated by the generation of the gasdermin-D N-terminal fragment. NASH susceptibility and pyroptosis were examined following knockdown of SMS1, protein kinase Cδ (PKCδ), or the NLR family CARD domain-containing protein 4 (NLRC4).

RESULTS:

HFHCD increased the hepatic levels of SM and DAG while decreasing the level of phosphatidylcholine. Hepatic expression of Sms1 but not Sms2 was higher in mouse models and patients with NASH. FC in hepatocytes induced Sms1 expression, and Sms1 knockdown prevented HFHCD-induced NASH. DAG produced by SMS1 activated PKCδ and NLRC4 inflammasome to induce hepatocyte pyroptosis. Depletion of Nlrc4 prevented hepatocyte pyroptosis and the development of NASH. Conditioned media from pyroptotic hepatocytes activated the NOD-like receptor family pyrin domain containing 3 inflammasome (NLRP3) in Kupffer cells, but Nlrp3 knockout mice were not protected against HFHCD-induced hepatocyte pyroptosis.

CONCLUSION:

SMS1 mediates hepatocyte pyroptosis through a novel DAG-PKCδ-NLRC4 axis and holds promise as a therapeutic target for NASH.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transferases (Other Substituted Phosphate Groups) / Hepatocytes / Non-alcoholic Fatty Liver Disease / Pyroptosis Limits: Animals Language: En Journal: Gut Year: 2021 Document type: Article Affiliation country: South Korea

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transferases (Other Substituted Phosphate Groups) / Hepatocytes / Non-alcoholic Fatty Liver Disease / Pyroptosis Limits: Animals Language: En Journal: Gut Year: 2021 Document type: Article Affiliation country: South Korea